Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study
Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Hugo MacGowan1, Oliver I Brown1, Michael Drozd1
1Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Insights
Heart failure (HF) often occurs in patients with existing conditions. Comorbidities accumulate over a decade before HF diagnosis, presenting opportunities for early intervention and prevention.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Heart failure (HF) is a complex condition frequently accompanied by multiple comorbidities.
- Understanding the sequence and timing of comorbidity accrual is crucial for developing preventative strategies.
Purpose of the Study:
- To define the trajectory of comorbidity accrual in relation to heart failure diagnosis.
- To identify potential windows for disease prevention in individuals at risk for HF.
Main Methods:
- Utilized UK Biobank cohort data (n=9824) including primary and secondary care records.
- Analyzed the time between HF diagnosis and 16 common comorbidities.
- Conducted stratified analyses by sex and age at HF diagnosis.
Main Results:
- Heart failure was the median fourth diagnosis chronologically.
- Comorbidities accumulated for over a decade prior to HF, accelerating in the years preceding diagnosis.
- Depression preceded HF by a median of 10.7 years; dementia by 0.7 years. All comorbidities appeared earlier in women.
- Atrial fibrillation/flutter, hypertension, cancer, myocardial infarction, and osteoarthritis were common preceding conditions.
Conclusions:
- Heart failure diagnosis typically occurs in individuals with established multiple long-term conditions.
- A significant window exists for interventions to prevent HF, even in non-traditional contexts like cancer and osteoarthritis care.
Aims:
Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention.
Methods And Results:
We identified all participants in the UK Biobank cohort study diagnosed with HF prior to enrolment or during follow-up, who had disease occurrence data available from both primary and secondary care records (n = 9824). We established the time between diagnosis of HF and 16 common comorbidities to determine the rate and sequence of comorbidity accrual in relation to HF. Stratified analyses considered associations with sex and age at diagnosis of HF. In chronological sequence, HF was the median fourth diagnosis for men and women. As the age at HF diagnosis increased, HF came later in the sequence of diseases (median second in under 50 years to fifth in those aged 80-90 years). In all age strata, comorbidities accumulated for over a decade before HF and this accelerated in the years immediately before HF. The median time between comorbidity and HF diagnoses ranged from depression preceding HF by 10.7 years to dementia proceeding HF by 0.7 years; all comorbidities presented earlier in women. Atrial fibrillation/flutter was the commonest disease to immediately precede HF, followed by hypertension, cancer, myocardial infarction and osteoarthritis.
Conclusion:
Heart failure is most often diagnosed in people with established multiple long-term conditions. There is a protracted window of opportunity during which interventions to prevent HF could be applied, often in disease contexts where this is not routine care, such as cancer and osteoarthritis.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...